These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2855092)

  • 1. [Use of the zwitterion detergent Sulfobetain-12 for preparation of virosomes and investigation of their immunogenic and protective properties].
    Mazhul' LA; Smirnova GV; Lotte VD; Zhigis LS; Reshetov PD
    Mol Gen Mikrobiol Virusol; 1988 Dec; (12):42-7. PubMed ID: 2855092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
    Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H
    Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity.
    de Mare A; Bungener LB; Regts J; de Vries-Idema J; van der Zee AG; Wilschut J; Daemen T
    Vaccine; 2008 May; 26(19):2314-21. PubMed ID: 18400343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
    Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
    Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
    J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isolation of influenza virus hemagglutinin by solubilization with the nonionic detergent O-14].
    Krivorutchenko IuL; Krivoshein IuS; Azhitskiĭ GIu; Rud'ko AP
    Mikrobiol Zh (1978); 1987; 49(3):72-5. PubMed ID: 3150495
    [No Abstract]   [Full Text] [Related]  

  • 8. Peculiarities of influenza infection caused by highly and poorly immunogenic strains of influenza virus.
    Frolov AF; Skripchenko GS; Shcherbinskaya AM; Vlasova AG; Rybakova TM
    J Hyg Epidemiol Microbiol Immunol; 1984; 29(3):303-9. PubMed ID: 6544322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine.
    Lambkin R; Oxford JS; Bossuyt S; Mann A; Metcalfe IC; Herzog C; Viret JF; Glück R
    Vaccine; 2004 Oct; 22(31-32):4390-6. PubMed ID: 15474733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
    Kostolanský F; Mucha V; Slováková R; Varecková E
    Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccinating effect of conjugates of influenza virus surface antigens with a synthetic polymer carrier].
    Petrov RV; Zhdanov VM; Kabanov VA; Khaitov RM; Norimov ASh
    Dokl Akad Nauk SSSR; 1984; 277(3):752-5. PubMed ID: 6489120
    [No Abstract]   [Full Text] [Related]  

  • 13. [Virus-inhibiting properties of the carbonyl-conjugated pentaene roseofungin].
    Shneĭder MA; Shtil'bans EB; Rachkovskaia LA; Vetlugina LA; Nikitina ET
    Antibiotiki; 1984 May; 29(5):344-9. PubMed ID: 6331293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
    Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.
    Cerwenka A; Morgan TM; Dutton RW
    J Immunol; 1999 Nov; 163(10):5535-43. PubMed ID: 10553081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.
    Kreijtz JH; Bodewes R; van Amerongen G; Kuiken T; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Vaccine; 2007 Jan; 25(4):612-20. PubMed ID: 17005299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage.
    de Jonge J; Amorij JP; Hinrichs WL; Wilschut J; Huckriede A; Frijlink HW
    Eur J Pharm Sci; 2007 Sep; 32(1):33-44. PubMed ID: 17628452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of protective and non-protective T cell epitopes in influenza.
    Crowe SR; Miller SC; Woodland DL
    Vaccine; 2006 Jan; 24(4):452-6. PubMed ID: 16140438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.
    Fan J; Liang X; Horton MS; Perry HC; Citron MP; Heidecker GJ; Fu TM; Joyce J; Przysiecki CT; Keller PM; Garsky VM; Ionescu R; Rippeon Y; Shi L; Chastain MA; Condra JH; Davies ME; Liao J; Emini EA; Shiver JW
    Vaccine; 2004 Aug; 22(23-24):2993-3003. PubMed ID: 15297047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.